Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours (Q34762171)

4 August 2017

1 reference

title

Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours (English)

1 reference

4 August 2017

1 reference

3

1 reference

4 August 2017

7

Beliën JA

1 reference

4 August 2017

Vermeulen PB

1

1 reference

4 August 2017

Gasparini G

2

1 reference

4 August 2017

Colpaert C

4

1 reference

4 August 2017

Marson LP

5

1 reference

4 August 2017

Gion M

6

1 reference

4 August 2017

de Waal RM

8

1 reference

4 August 2017

Van Marck E

9

1 reference

4 August 2017

Magnani E

10

1 reference

4 August 2017

Weidner N

11

1 reference

4 August 2017

Harris AL

12

1 reference

4 August 2017

Dirix LY

13

1 reference

4 August 2017

1 August 2002

1 reference

European Journal of Cancer

4 August 2017

1 reference

4 August 2017

38

1 reference

4 August 2017

12

1 reference

4 August 2017

1564-1579

1 reference

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Angiogenesis in primary lung cancer and lung secondaries

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vasculogenic mimicry: how convincing, how novel, and how significant?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Endothelial and macrophage upregulation of urokinase receptor expression in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Early and Extensive Contribution of Pericytes/Vascular Smooth Muscle Cells to Microvascular Proliferation in Glioblastoma Multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Correlation of the fractions of proliferating tumor and endothelial cells in breast and colorectal adenocarcinoma is independent of tumor histiotype and microvessel density

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Intratumoral microvessel density and expression of ED-A/ED-B sequences of fibronectin in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Heterogeneous vascular dependence of tumor cell populations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Serum vascular endothelial growth factor levels in various liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Circulating vascular endothelial growth factor in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Serum VEGF levels in women with a benign breast tumor or breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Clinical implications of circulating angiogenic factors in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Cytosol Vascular Endothelial Growth Factor in Endometrial Carcinoma: Correlation with Disease-Free Survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Quantitative analysis of vascular endothelial growth factor in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Clinical significance of determination of surrogate markers of angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Tumour vascularity is not a prognostic factor for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

Reproducibility of microvessel counts in breast cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900094-1

7 January 2021

10.1016/S0959-8049(02)00094-1

Identifiers

DOI

1 reference

release_nczji33vbzc3djovzstpiphrfu

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nczji33vbzc3djovzstpiphrfu

24 November 2022

mapped directly with Wikidata item

1 reference